---
$id: https://graph.org.ai/products/commodity/51143012
$type: Product
source: UNSPSC
code: "51143012"
title: "Leteprinim"
class: "51143000"
classTitle: "Nootropics"
family: "51140000"
familyTitle: "Central nervous system drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Leteprinim

**UNSPSC Code**: 51143012
**Class**: [Nootropics](Nootropics.mdx)
**Family**: [Central nervous system drugs](../Central nervous system drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a neuroprotective agent with the molecular formula C15H13N5O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier NBY3IU407M, chemically known as 4-((3-(1,6-dihydro-6-oxo-9h-purin-9-yl)-1-oxopropyl)amino)benzoic acid but generally known as leteprinim, which bears US NIH Compound Identifier 132123. European Medicines Agency schedules Leteprinim in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB02897MIG. The term LETEPRINIM is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 13 No. 3, 1999, List 42). Most nations schedule leteprinim under HS 29335995 and SITC 51576. As of Q4 2014, LETEPRINIM remains the US FDA Preferred Term for this commodity. Leteprinim bears US NLM identifiers UMLS ID C0252664 and NCI Concept Code C80995. SMILES: O=C(NC1CCC(CC1)C(=O)O)CCN1C2[NH]CNC(=O)C2NC1.

